QGL — Transcutaneous Nerve Stimulator For Adhd Class II

FDA Device Classification

FDA product code QGL covers "Transcutaneous Nerve Stimulator For Adhd", a Class II medical device regulated under 21 CFR 882.5898. Submissions are reviewed by the Neurology panel. At least 5 recent 510(k) clearances have been granted under this product code.

Classification details

Product Code
QGL
Device Class
Class II
Regulation Number
882.5898
Submission Type
510(k)
Review Panel
NE
Medical Specialty
Neurology
Implant
No

Definition

A transcutaneous electrical nerve stimulator for Attention Deficit Hyperactivity Disorder (ADHD) is a prescription device that stimulates transcutaneously or percutaneously through electrodes placed on the forehead.

Recent 510(k) clearances

K-NumberApplicantDevice NameDate
K243289Nu Eyne CoADDNOX (BPSPM1)Jan 16, 2025
K232991Bistos CoBT-1000Aug 28, 2024
K233293NeurosigmaGeneration 2.0 Monarch external Trigeminal Nerve Stimulation (eTNS) System®Jan 16, 2024
K213629Nu Eyne CoSMILEFeb 12, 2023
DEN180041NeurosigmaMonarch eTNS SystemApr 19, 2019

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.